510(k) K113181
K113181 is an FDA 510(k) premarket notification submitted by Veridex, LLC for the device "CELLTRACKS ANALYER II". The FDA issued a decision of Substantially Equivalent on Dec 12, 2011. The device falls under product code NQI (System, Immunomagnetic, Circulating Cancer Cell, Enumeration), a Class II device regulated under 21 CFR 866.6020. Veridex, LLC has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 12, 2011
- Date Received
- Oct 28, 2011
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Immunomagnetic, Circulating Cancer Cell, Enumeration
- Device Class
- Class II
- Regulation Number
- 866.6020
- Review Panel
- PA
- Submission Type
- 510(k)
In vitro diagnostic device to aid in the enumeration of immunomagnetically selected and fluorescently identified circulating tumor cells of epithelial origin in whole blood for prediction of cancer progression and survival.
Need the full FDA record for Veridex, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.